Business Description
Thermo Fisher Scientific Inc
NAICS : 541380
SIC : 3826
168 Third Avenue, Waltham, MA, USA, 02451
Compare
Compare
Traded in other countries / regions
TMO.Argentina
•
TMOF.Austria
•
TMOS34.Brazil
•
TN8.Germany
•
TMO.Mexico
•
TMO.Peru
•
TFS.Switzerland
•
0R0H.UK
•
TMO.USA
Description
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2022 (revenue figures include some cross-segment revenue): analytical technologies (15% of sales); specialty diagnostic products (10%); life science solutions (30%); and lab products and services, which includes CRO services (51%).
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.72 | |||||
Debt-to-EBITDA | 2.51 | |||||
Interest Coverage | 16.98 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 4.44 | |||||
Beneish M-Score | -2.12 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 18.1 | |||||
3-Year EBITDA Growth Rate | 25.5 | |||||
3-Year EPS without NRI Growth Rate | 39 | |||||
3-Year FCF Growth Rate | 22.4 | |||||
3-Year Book Growth Rate | 14.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Industry Rank | 6.83 | |||||
Future 3-5Y Total Revenue Growth Rate Industry Rank | 7.28 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 70.16 | |||||
9-Day RSI | 67.2 | |||||
14-Day RSI | 64.14 | |||||
6-1 Month Momentum % | -2.09 | |||||
12-1 Month Momentum % | -2.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.65 | |||||
Quick Ratio | 1.13 | |||||
Cash Ratio | 0.17 | |||||
Days Inventory | 82.2 | |||||
Days Sales Outstanding | 59.06 | |||||
Days Payable | 39.99 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.19 | |||||
Dividend Payout Ratio | 0.06 | |||||
3-Year Dividend Growth Rate | 15.2 | |||||
Forward Dividend Yield % | 0.2 | |||||
5-Year Yield-on-Cost % | 0.34 | |||||
3-Year Average Share Buyback Ratio | 0.6 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 46.63 | |||||
Operating Margin % | 22.72 | |||||
Net Margin % | 17.37 | |||||
ROE % | 18.63 | |||||
ROA % | 8.86 | |||||
ROIC % | 12.06 | |||||
ROC (Joel Greenblatt) % | 74.12 | |||||
ROCE % | 12.31 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 31.82 | |||||
Forward PE Ratio | 26.2 | |||||
PE Ratio without NRI | 31.82 | |||||
Shiller PE Ratio | 60.39 | |||||
Price-to-Owner-Earnings | 35.47 | |||||
PEG Ratio | 1.35 | |||||
PS Ratio | 5.53 | |||||
PB Ratio | 5.54 | |||||
Price-to-Free-Cash-Flow | 37.38 | |||||
Price-to-Operating-Cash-Flow | 26.8 | |||||
EV-to-EBIT | 28.96 | |||||
EV-to-Forward-EBIT | 24.72 | |||||
EV-to-EBITDA | 21.75 | |||||
EV-to-Forward-EBITDA | 22.31 | |||||
EV-to-Revenue | 6.14 | |||||
EV-to-Forward-Revenue | 6.12 | |||||
EV-to-FCF | 41.71 | |||||
Price-to-Projected-FCF | 2.23 | |||||
Price-to-DCF (Earnings Based) | 0.84 | |||||
Price-to-DCF (FCF Based) | 1.28 | |||||
Price-to-Median-PS-Value | 1.48 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.28 | |||||
Earnings Yield (Greenblatt) % | 3.45 | |||||
Forward Rate of Return (Yacktman) % | 22.16 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NYSE:TMO
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 42,820 | ||
EPS (TTM) ($) | 18.79 | ||
Beta | 0.7 | ||
Volatility % | 25.55 | ||
14-Day RSI | 64.14 | ||
14-Day ATR ($) | 12.569072 | ||
20-Day SMA ($) | 584.8615 | ||
12-1 Month Momentum % | -2.81 | ||
52-Week Range ($) | 497.83 - 672.34 | ||
Shares Outstanding (Mil) | 391.79 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Thermo Fisher Scientific Inc Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |